As of May 24, 2025, Embecta Corp (EMBC) reports a Current Ratio of 2.03.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Embecta Corp's Current Ratio
Over recent years, Embecta Corp's Current Ratio has shown a stable trend. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-09-30 | 2.03 |
| 2023-09-30 | 2.12 |
| 2022-09-30 | 2.21 |
| 2021-09-30 | 1.78 |
| 2020-09-30 | 1.72 |
This slight downward trend highlights how Embecta Corp manages its short-term assets and liabilities over time.
Comparing Embecta Corp's Current Ratio to Peers
To better understand Embecta Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Embecta Corp (EMBC) | 2.03 |
| Access Bio Inc (950130.KQ) | 9.51 |
| Lantheus Holdings Inc (LNTH) | 5.52 |
| STAAR Surgical Co (STAA) | 5.23 |
| Merit Medical Systems Inc (MMSI) | 4.27 |
| ICU Medical Inc (ICUI) | 2.59 |
Compared to its competitors, Embecta Corp's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.